Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

DOI Full Paper Access

1.2K

Citations

18

References

2020

Year

Shengli Xia, Yuntao Zhang, Yanxia Wang, Hui Wang, Yunkai Yang, George F. Gao, Wenjie Tan, Guizhen Wu, Miao Xu, Zhiyong Lou,

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVaccine EfficacyInactivated Sars-cov-2 VaccineMedicineCovid-19

References

	Year	Citations

Page 1

Page 1